Overview
NRXS market data
Price History
NRXS price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$0.86 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.50 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -170.1% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $2.20 – $9.33 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $85.7M · P/B 14.23 · P/S 20.02.
Company News
Neuraxis shares are trading lower after the company reported mixed Q2 financial results.Benzinga · Aug 11, 2026, 1:23 PM
Neuraxis Q2 EPS $(0.19) Beats $(0.32) Estimate, Sales $1.929M Miss $2.000M EstimateBenzinga · Aug 11, 2026, 11:11 AM
NeurAxis Announces Additional Medical Policy Coverage For PENFS Representing Over 500,000 Covered Lives, Expanding IB-Stim Access In Mid-Atlantic RegionBenzinga · Aug 4, 2026, 11:33 AM
8-K filing — Neuraxis, INC (NRXS)SEC EDGAR · Jul 10, 2026, 11:00 AM